Concordia Care Presents Expert Guidance on Clinical, Administrative and Risk Implications of Complex Substance Use Disorder Cases at 5th Annual AMS Claims Symposium

June 26-28, 2018, Beauport Hotel, Gloucester, MA

MIAMI--()--Concordia Care, Inc. (Concordia), a specialty risk-transfer company, announces that its upcoming presentation at the 5th Annual AMS Claims Symposium, June 27, 9:15 a.m. to 10:30 a.m. ET, provides expert clinical guidance on prevalence and impact of substance use disorders in workers’ compensation. Developed by Alana Letourneau, M.D., MBA, vice president, Clinical Program Strategy, and David Vittoria, LCSW, MCAP, ICADC, NCAC II, vice president, Clinical Services, the presentation also focuses on the connection between opioids and the brain, as well as early identification of complex cases where new advances in treatment can have positive impact.

“Addiction is a disease that requires providers to address both the clinical and behavioral health components of treatment, including full biopsychosocial evaluation, coordination of care, and evidence-based treatment approaches,” says Dr. Letourneau. “This presentation will also focus on levels of care determination and medical necessity criteria for addiction treatment, with a full discussion of their impact on opioid claims. We will highlight new advances in opioid treatment, including medication and therapy interventions and their inclusion in health plan coverage.”

David Vittoria explains that pain and disability involve dynamic interactions among physiological, psychological and social factors, adding, “Trying to manage any one of these areas to the exclusion of the others is a futile effort. We need to treat the individual in the context of the environment in which these patients live, work and play to be most effective in maximizing individual outcomes and lowering long term cost of care for complex cases.”

About Concordia Care, Inc.

Concordia Care, Inc. (Concordia) is a specialty risk transfer, care-coordination company serving insurers, government entities, self-insured plan sponsors and other managed care organizations. Concordia aims to improve patient-centered outcomes and reduce overall cost of quality care. Founded as a Managed Behavioral Health Organization, Concordia has evolved its health services business to focus on: risk transfer, behavioral health, health technology and specialty services. Concordia holds dual accreditations from the Accreditation Association for Ambulatory Healthcare Inc. (AAAHC) and the National Committee for Quality Assurance (NCQA). Visit www.concordiacare.com. Concordia is an MBF Healthcare Partners portfolio company.

Contacts

Media:
CPR Communications for Concordia
Brittany Tedesco, 201-641-1911 x 14
btedesco@cpronline.com

Release Summary

Concordia Presents Expert Guidance on Clinical, Administrative & Risk Implications of Complex Substance Use Disorder Cases at AMS Claims Symposium

Contacts

Media:
CPR Communications for Concordia
Brittany Tedesco, 201-641-1911 x 14
btedesco@cpronline.com